Form 8-K - Current report:
SEC Accession No. 0001398733-25-000012
Filing Date
2025-08-11
Accepted
2025-08-11 16:05:47
Documents
56
Period of Report
2025-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20250811.htm   iXBRL 8-K 31679
2 EX-99.1 q22025-ex991earningsrelease.htm EX-99.1 236866
3 EX-99.2 q22025supplementalearnin.htm EX-99.2 18142
4 EX-99.3 aquestive_corppresentati.htm EX-99.3 30795
8 aqstlogo.jpg GRAPHIC 14528
9 aquestive_corppresentati001.jpg GRAPHIC 98413
10 aquestive_corppresentati002.jpg GRAPHIC 338952
11 aquestive_corppresentati003.jpg GRAPHIC 105781
12 aquestive_corppresentati004.jpg GRAPHIC 117049
13 aquestive_corppresentati005.jpg GRAPHIC 125849
14 aquestive_corppresentati006.jpg GRAPHIC 118602
15 aquestive_corppresentati007.jpg GRAPHIC 111476
16 aquestive_corppresentati008.jpg GRAPHIC 103454
17 aquestive_corppresentati009.jpg GRAPHIC 50802
18 aquestive_corppresentati010.jpg GRAPHIC 117028
19 aquestive_corppresentati011.jpg GRAPHIC 101711
20 aquestive_corppresentati012.jpg GRAPHIC 118151
21 aquestive_corppresentati013.jpg GRAPHIC 94276
22 aquestive_corppresentati014.jpg GRAPHIC 131156
23 aquestive_corppresentati015.jpg GRAPHIC 116732
24 aquestive_corppresentati016.jpg GRAPHIC 107052
25 aquestive_corppresentati017.jpg GRAPHIC 80709
26 aquestive_corppresentati018.jpg GRAPHIC 111155
27 aquestive_corppresentati019.jpg GRAPHIC 38921
28 aquestive_corppresentati020.jpg GRAPHIC 115611
29 aquestive_corppresentati021.jpg GRAPHIC 137177
30 aquestive_corppresentati022.jpg GRAPHIC 113534
31 aquestive_corppresentati023.jpg GRAPHIC 131684
32 aquestive_corppresentati024.jpg GRAPHIC 68561
33 aquestive_corppresentati025.jpg GRAPHIC 37241
34 q22025supplementalearnin001.jpg GRAPHIC 104992
35 q22025supplementalearnin002.jpg GRAPHIC 285843
36 q22025supplementalearnin003.jpg GRAPHIC 143004
37 q22025supplementalearnin004.jpg GRAPHIC 81019
38 q22025supplementalearnin005.jpg GRAPHIC 45467
39 q22025supplementalearnin006.jpg GRAPHIC 110917
40 q22025supplementalearnin007.jpg GRAPHIC 124600
41 q22025supplementalearnin008.jpg GRAPHIC 122594
42 q22025supplementalearnin009.jpg GRAPHIC 131289
43 q22025supplementalearnin010.jpg GRAPHIC 126455
44 q22025supplementalearnin011.jpg GRAPHIC 41177
45 q22025supplementalearnin012.jpg GRAPHIC 72192
46 q22025supplementalearnin013.jpg GRAPHIC 92743
47 q22025supplementalearnin014.jpg GRAPHIC 68661
48 q22025supplementalearnin015.jpg GRAPHIC 37241
  Complete submission text file 0001398733-25-000012.txt   6531761

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20250811.xsd EX-101.SCH 1776
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20250811_lab.xml EX-101.LAB 21629
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20250811_pre.xml EX-101.PRE 12504
58 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20250811_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 251201991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)